After completing the independent medical educational activity, learners will be able to:
- Understand and explain relevant and current clinical trials and updates regarding immunotherapy as maintenance therapy in la/mUC patients.
- Learn and understand which patients should be followed up with immunotherapy maintenance treatment.
Panelists: Shilpa Gupta, Vadim Koshkin and Jorge A. Garcia
*Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, *Division of Hematology and Oncology, University of California San Francisco and *Oncology University Hospitals Seidman Cancer Center, Cleveland, OH, USA.
Certificate of attendance: The certificates will be given to those attendees who will complete pre & post symposium evaluation quiz.
Conflict of interests: No known conflict of interests
Acknowledgment: This symposium is supported by an educational grant from Pfizer and Merck.